Intravenous (IV) Solution Manufacturing in the US - Industry Market Research Report
Description
Intravenous (IV) Solution Manufacturing in the US
Intravenous (IV) solution manufacturers supply hospitals and healthcare facilities with essential IV products. The steady growth in hospital demand and the crucial nature of medical treatments have provided some safeguards against economic downturns. In 2020, when faced with COVID-19 restrictions, industry revenue increased as most hospitalized patients needed IV products. But rising plastic materials and resin costs paired with a decline in overall health expenditure have curbed growth rates. As a result, industry-wide revenue has grown at a modest CAGR of 0.2% to $2.0 billion over the five years to 2023, including a 3.6% bounce back in revenue in 2023 alone.
Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Intravenous (IV) solution manufacturers supply hospitals and healthcare facilities with essential IV products. The steady growth in hospital demand and the crucial nature of medical treatments have provided some safeguards against economic downturns. In 2020, when faced with COVID-19 restrictions, industry revenue increased as most hospitalized patients needed IV products. But rising plastic materials and resin costs paired with a decline in overall health expenditure have curbed growth rates. As a result, industry-wide revenue has grown at a modest CAGR of 0.2% to $2.0 billion over the five years to 2023, including a 3.6% bounce back in revenue in 2023 alone.
Companies in this industry primarily engage in manufacturing substances that may be infused directly into a vein using a venous access device. Intravenous (IV) solutions may be used to correct electrolyte imbalances, to deliver medications, for blood transfusion or as fluid replacement. Solutions specifically for animals are excluded from this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
41 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
